Technical analysis of Caris Life Sciences, Inc. (CAI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms.
Price Performance
| 1 month | +21.22% |
| 3 months | +75.46% |
| Year-to-date | +12.64% |
| 1 year | -7.38% |
52-Week Range
| 52-week High | $33.65 |
| 52-week Low | $14.19 |
| Avg Volume (90d) | 4.3M |
Technical Indicators
| SMA 50 | $24.75 |
| SMA 200 | $21.23 |
| Beta | 1.33 |
| 30-day Volatility (annualised) | 61.9% |
| Price vs SMA 50 | +22.8% |
| Price vs SMA 200 | +43.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-11 | $25.53 | |
| 2025-12 | $26.98 | +5.7% |
| 2026-01 | $23.16 | -14.2% |
| 2026-02 | $20.14 | -13.0% |
| 2026-03 | $17.88 | -11.2% |
| 2026-04 | $19.00 | +6.3% |
| 2026-05 | $16.72 | -12.0% |
| 2026-06 | $17.82 | +6.6% |
| 2026-07 | $15.67 | -12.1% |
| 2026-08 | $25.49 | +62.7% |
| 2026-09 | $30.63 | +20.2% |
| 2026-10 | $30.39 | -0.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $0.03 | $256M |
| 2026-08-05 | $0.01 | $238M |
| 2026-05-07 | $-0.02 | $209M |
| 2026-02-26 | $0.01 | $210M |
| 2025-11-05 | $-0.08 | $174M |
| 2025-08-12 | $-0.21 | $138M |
| 2025-06-09 | $-0.22 | $138M |
Price
| Price | $30.39 |
| Market Cap | $8.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 76.10 |
| Price / Book | 13.53 |
| EV / EBITDA | 48.37 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.76 |
| Current Ratio | 5.53 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 6.95 |